165 related articles for article (PubMed ID: 37224762)
21. New 1,2,3-triazole/1,2,4-triazole hybrids linked to oxime moiety as nitric oxide donor selective COX-2, aromatase, B-RAF
Fadaly WAA; Nemr MTM; Zidan TH; Mohamed FEA; Abdelhakeem MM; Abu Jayab NN; Omar HA; Abdellatif KRA
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2290461. PubMed ID: 38061801
[TBL] [Abstract][Full Text] [Related]
22. 1,2,3-triazole tethered Indole-3-glyoxamide derivatives as multiple inhibitors of 5-LOX, COX-2 & tubulin: Their anti-proliferative & anti-inflammatory activity.
Naaz F; Preeti Pallavi MC; Shafi S; Mulakayala N; Shahar Yar M; Sampath Kumar HM
Bioorg Chem; 2018 Dec; 81():1-20. PubMed ID: 30081353
[TBL] [Abstract][Full Text] [Related]
23. Selective cyclooxygenase inhibition and ulcerogenic liability of some newly prepared anti-inflammatory agents having thiazolo[4,5-d]pyrimidine scaffold.
Bakr RB; Ghoneim AA; Azouz AA
Bioorg Chem; 2019 Jul; 88():102964. PubMed ID: 31075742
[TBL] [Abstract][Full Text] [Related]
24. New tilomisole-based benzimidazothiazole derivatives as anti-inflammatory agents: Synthesis, in vivo, in vitro evaluation, and in silico studies.
Darwish SA; El-Kerdawy MM; Elsheakh AR; Abdelrahman RS; Shaldam MA; Abdel-Aziz HA; Hassan GS; Ghaly MA
Bioorg Chem; 2022 Mar; 120():105644. PubMed ID: 35121552
[TBL] [Abstract][Full Text] [Related]
25. Novel 1,2,4-triazine-quinoline hybrids: The privileged scaffolds as potent multi-target inhibitors of LPS-induced inflammatory response via dual COX-2 and 15-LOX inhibition.
Ghanim AM; Rezq S; Ibrahim TS; Romero DG; Kothayer H
Eur J Med Chem; 2021 Jul; 219():113457. PubMed ID: 33892270
[TBL] [Abstract][Full Text] [Related]
26. Design and synthesis of pyrimidine-5-carbonitrile hybrids as COX-2 inhibitors: Anti-inflammatory activity, ulcerogenic liability, histopathological and docking studies.
Alfayomy AM; Abdel-Aziz SA; Marzouk AA; Shaykoon MSA; Narumi A; Konno H; Abou-Seri SM; Ragab FAF
Bioorg Chem; 2021 Mar; 108():104555. PubMed ID: 33376011
[TBL] [Abstract][Full Text] [Related]
27. Novel class of benzimidazole-thiazole hybrids: The privileged scaffolds of potent anti-inflammatory activity with dual inhibition of cyclooxygenase and 15-lipoxygenase enzymes.
Maghraby MT; Abou-Ghadir OMF; Abdel-Moty SG; Ali AY; Salem OIA
Bioorg Med Chem; 2020 Apr; 28(7):115403. PubMed ID: 32127262
[TBL] [Abstract][Full Text] [Related]
28. 1-(4-Methoxyphenyl)-5-(3,4,5-trimethoxyphenyl)-1H-1,2,4-triazole-3-carboxamides: synthesis, molecular modeling, evaluation of their anti-inflammatory activity and ulcerogenicity.
Abdel-Aziz M; Beshr EA; Abdel-Rahman IM; Ozadali K; Tan OU; Aly OM
Eur J Med Chem; 2014 Apr; 77():155-65. PubMed ID: 24631895
[TBL] [Abstract][Full Text] [Related]
29. New indomethacin analogs as selective COX-2 inhibitors: Synthesis, COX-1/2 inhibitory activity, anti-inflammatory, ulcerogenicity, histopathological, and docking studies.
Abdellatif KRA; Abdelall EKA; Elshemy HAH; El-Nahass ES; Abdel-Fattah MM; Abdelgawad YYM
Arch Pharm (Weinheim); 2021 Apr; 354(4):e2000328. PubMed ID: 33314237
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis, analgesic, anti-inflammatory activity of novel pyrazolones possessing aminosulfonyl pharmacophore as inhibitors of COX-2/5-LOX enzymes: Histopathological and docking studies.
Abdelgawad MA; Labib MB; Ali WAM; Kamel G; Azouz AA; El-Nahass ES
Bioorg Chem; 2018 Aug; 78():103-114. PubMed ID: 29550530
[TBL] [Abstract][Full Text] [Related]
31. Trimethoxyphenyl containing compounds: Synthesis, biological evaluation, nitric oxide release, modeling, histochemical and histopathological studies.
Abdelall EKA; Lamie PF; Aboelnaga LS; Hassan RM
Bioorg Chem; 2022 Jul; 124():105806. PubMed ID: 35436752
[TBL] [Abstract][Full Text] [Related]
32. Novel benzenesulfonamide and 1,2-benzisothiazol-3(2H)-one-1,1-dioxide derivatives as potential selective COX-2 inhibitors.
Taher ES; Ibrahim TS; Fares M; Al-Mahmoudy AMM; Radwan AF; Orabi KY; El-Sabbagh OI
Eur J Med Chem; 2019 Jun; 171():372-382. PubMed ID: 30928709
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis and molecular modeling of novel aryl carboximidamides and 3-aryl-1,2,4-oxadiazoles derived from indomethacin as potent anti-inflammatory iNOS/PGE2 inhibitors.
Mohamed MFA; Marzouk AA; Nafady A; El-Gamal DA; Allam RM; Abuo-Rahma GEA; El Subbagh HI; Moustafa AH
Bioorg Chem; 2020 Dec; 105():104439. PubMed ID: 33161252
[TBL] [Abstract][Full Text] [Related]
34. Novel 1-[4-(Aminosulfonyl)phenyl]-1H-1,2,4-triazole derivatives with remarkable selective COX-2 inhibition: design, synthesis, molecular docking, anti-inflammatory and ulcerogenicity studies.
Abuo-Rahma Gel-D; Abdel-Aziz M; Farag NA; Kaoud TS
Eur J Med Chem; 2014 Aug; 83():398-408. PubMed ID: 24983538
[TBL] [Abstract][Full Text] [Related]
35. Synthesis of new compounds bearing methyl sulfonyl pharmacophore as selective COX-2 inhibitor.
Almarsoomi T; Osmaniye D; Sağlık BN; Levent S; Ghani U; Özkay Y; Kaplancıklı ZA
J Mol Recognit; 2023 Jul; 36(7):e3025. PubMed ID: 37191245
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and biological evaluation of new nicotinate derivatives as potential anti-inflammatory agents targeting COX-2 enzyme.
El-Dash Y; Khalil NA; Ahmed EM; Hassan MSA
Bioorg Chem; 2021 Feb; 107():104610. PubMed ID: 33454504
[TBL] [Abstract][Full Text] [Related]
37. Design and synthesis of novel 4-fluorobenzamide-based derivatives as promising anti-inflammatory and analgesic agents with an enhanced gastric tolerability and COX-inhibitory activity.
Halim PA; Georgey HH; George MY; El Kerdawy AM; Said MF
Bioorg Chem; 2021 Oct; 115():105253. PubMed ID: 34390973
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of new multitarget-directed ligands containing thienopyrimidine nucleus for inhibition of 15-lipoxygenase, cyclooxygenases, and pro-inflammatory cytokines.
Abdelkhalek AS; Kothayer H; Rezq S; Orabi KY; Romero DG; El-Sabbagh OI
Eur J Med Chem; 2023 Aug; 256():115443. PubMed ID: 37182334
[TBL] [Abstract][Full Text] [Related]
39. Click chemistry synthesis, biological evaluation and docking study of some novel 2'-hydroxychalcone-triazole hybrids as potent anti-inflammatory agents.
Boshra AN; Abdu-Allah HHM; Mohammed AF; Hayallah AM
Bioorg Chem; 2020 Jan; 95():103505. PubMed ID: 31901755
[TBL] [Abstract][Full Text] [Related]
40. Discovery of potential anti-inflammatory drugs: diaryl-1,2,4-triazoles bearing N-hydroxyurea moiety as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase.
Jiang B; Huang X; Yao H; Jiang J; Wu X; Jiang S; Wang Q; Lu T; Xu J
Org Biomol Chem; 2014 Apr; 12(13):2114-27. PubMed ID: 24562695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]